- Filed
- Dec 22, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2026 · Nov 30, 2025 | 360.4M sh |
| Shares Diluted | Q2 2026 · Nov 30, 2025 | 361.1M sh |
| Shares Diluted | Q2 2026 · Nov 30, 2024 | 361.7M sh |
| Shares Diluted | Q2 2026 · Nov 30, 2024 | 361.8M sh |
| Shares Outstanding | Q2 2026 · Nov 30, 2025 | 358.97M sh |
| Stock Repurchased | Q2 2026 · Nov 30, 2025 | $286.6M |
| Stock Repurchased | Q2 2026 · Nov 30, 2024 | $104.5M |
| Dividends Paid | Q2 2026 · Nov 30, 2025 | $777M |
| Dividends Paid | Q2 2026 · Nov 30, 2024 | $706.2M |
| Capex | Q2 2026 · Nov 30, 2025 | $118M |
| Capex | Q2 2026 · Nov 30, 2024 | $82.6M |
| Operating Cash Flow | Q2 2026 · Nov 30, 2025 | $1.16B |
| Operating Cash Flow | Q2 2026 · Nov 30, 2024 | $841.1M |
| Long Term Debt | Q2 2026 · Nov 30, 2025 | $4.55B |
| Long Term Debt | Q2 2026 · May 31, 2025 | $4.55B |
| Short Term Debt | Q2 2026 · Nov 30, 2025 | $18.2M |
| Short Term Debt | Q2 2026 · May 31, 2025 | $18.6M |
| Cash And Equivalents | Q2 2026 · Nov 30, 2025 | $1.49B |
| Cash And Equivalents | Q2 2026 · May 31, 2025 | $1.63B |
| Cash And Equivalents | Q2 2026 · Nov 30, 2024 | $1.2B |
| Stockholders Equity | Q2 2026 · Nov 30, 2025 | $3.88B |
| Stockholders Equity | Q2 2026 · Aug 31, 2025 | $3.97B |
| Stockholders Equity | Q2 2026 · May 31, 2025 | $4.13B |
| Stockholders Equity | Q2 2026 · Nov 30, 2024 | $3.93B |
| Stockholders Equity | Q2 2026 · Aug 31, 2024 | $3.85B |
| Stockholders Equity | Q2 2026 · May 31, 2024 | $3.8B |
| Current Liabilities | Q2 2026 · Nov 30, 2025 | $7.04B |
| Current Liabilities | Q2 2026 · May 31, 2025 | $6.96B |
| Total Liabilities | Q2 2026 · Nov 30, 2025 | $12.64B |
| Total Liabilities | Q2 2026 · May 31, 2025 | $12.44B |
| Current Assets | Q2 2026 · Nov 30, 2025 | $8.91B |
| Current Assets | Q2 2026 · May 31, 2025 | $8.92B |
| Total Assets | Q2 2026 · Nov 30, 2025 | $16.52B |
| Total Assets | Q2 2026 · May 31, 2025 | $16.56B |
| Eps Diluted | Q2 2026 · Nov 30, 2025 | $1.10 |
| Eps Diluted | Q2 2026 · Nov 30, 2025 | $2.16 |
| Eps Diluted | Q2 2026 · Nov 30, 2024 | $1.14 |
| Eps Diluted | Q2 2026 · Nov 30, 2024 | $2.32 |
| Eps Basic | Q2 2026 · Nov 30, 2025 | $1.10 |
| Eps Basic | Q2 2026 · Nov 30, 2025 | $2.17 |
| Eps Basic | Q2 2026 · Nov 30, 2024 | $1.15 |
| Eps Basic | Q2 2026 · Nov 30, 2024 | $2.34 |
| Sga Expense | Q2 2026 · Nov 30, 2025 | $573.5M |
| Sga Expense | Q2 2026 · Nov 30, 2025 | $1.16B |
| Sga Expense | Q2 2026 · Nov 30, 2024 | $399.7M |
| Sga Expense | Q2 2026 · Nov 30, 2024 | $791.5M |
| Net Income | Q2 2026 · Nov 30, 2025 | $395.4M |
| Net Income | Q2 2026 · Nov 30, 2025 | $779.2M |
| Net Income | Q2 2026 · Nov 30, 2024 | $413.4M |
| Net Income | Q2 2026 · Nov 30, 2024 | $840.8M |
| Operating Income | Q2 2026 · Nov 30, 2025 | $571.9M |
| Operating Income | Q2 2026 · Nov 30, 2025 | $1.11B |
| Operating Income | Q2 2026 · Nov 30, 2024 | $538.1M |
| Operating Income | Q2 2026 · Nov 30, 2024 | $1.08B |
| Cost Of Revenue | Q2 2026 · Nov 30, 2025 | $412.2M |
| Cost Of Revenue | Q2 2026 · Nov 30, 2025 | $826M |
| Cost Of Revenue | Q2 2026 · Nov 30, 2024 | $379.1M |
| Cost Of Revenue | Q2 2026 · Nov 30, 2024 | $759.1M |
| Revenue | Q2 2026 · Nov 30, 2025 | $1.5B |
| Revenue | Q2 2026 · Nov 30, 2025 | $3B |
| Revenue | Q2 2026 · Nov 30, 2024 | $1.28B |
| Revenue | Q2 2026 · Nov 30, 2024 | $2.56B |